Clinical Trial: Safety and Tolerability Trial of Psilocybin in Healthy Older Adults

U.S., April 9 -- ClinicalTrials.gov registry received information related to the study (NCT07516405) titled 'Safety and Tolerability Trial of Psilocybin in Healthy Older Adults' on March 17.

Brief Summary: This study plans to learn more about the safety and tolerability of psychedelic administration (psilocybin) in healthy older adults ages 65-85.

Study Start Date: April 01

Study Type: INTERVENTIONAL

Condition: Healthy Volunteer Older Adults (65-85 Years)

Intervention: DRUG: Psilocybin (Usona Institute)

Evaluate the safety and tolerability of psychedelic administration in two cohorts of healthy older adults.

* Cohort 1a Psilocybin Moderate Dose: 2 doses of oral psilocybin (10mg and then 25mg) 30 days apart.

* Cohort 1b Psilocybin ...